Results for tag: "Glaucoma Procedures"

The Glaucoma Procedures market within the optical sector encompasses a range of medical interventions aimed at treating glaucoma, a group of eye conditions that can lead to optic nerve damage and vision loss, primarily due to elevated intraocular pressure. The market includes various types of surgical procedures and laser therapies that are essential for managing the disease. Procedures such as trabeculectomy, laser trabeculoplasty, and the installation of glaucoma drainage devices are widely performed to enhance aqueous humor outflow and reduce intraocular pressure. Minimally invasive glaucoma surgeries (MIGS) have also gained traction due to their potential for fewer complications and quicker recovery times. Additionally, advancements in imaging technologies, diagnostic tools, and pharmaceuticals complement the procedural aspect of the market, providing a comprehensive approach to glaucoma management. In the realm of companies operating within the glaucoma procedures market, several notable entities are recognized for their contributions and innovations. Companies such as Allergan, Novartis (through its Alcon division), Johnson & Johnson Vision, Glaukos Corporation, and Zeiss have established strong positions with their diverse range of products and services. These companies excel in different segments, offering surgical devices, implants, laser systems, and advanced diagnostic equipment that cater to the evolving needs of ophthalmology and specifically, the management of glaucoma. Show Less Read more